Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is 0.28% vs 0.56% in Mar 2024
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2025 is -8.98% vs -10.51% in Mar 2024
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2025 is 3.26% vs 24.80% in Mar 2024
Compare Balance Sheet Results of Norris Medicines
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
9.93
51.00
-41.07
-80.53%
Share Warrants & Outstandings
Total Reserve
-24.79
-10.70
-14.09
-131.68%
Shareholder's Funds
-14.87
40.30
-55.17
-136.90%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
18.53
0.00
18.53
0.00%
Secured Loans
0.00
0.00
0.00
0.00%
Unsecured Loans
18.53
0.00
18.53
0.00%
Deferred Tax Assets / Liabilities
-0.90
0.27
-1.17
-433.33%
Other Long Term Liabilities
0.00
0.00
0.00
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.00
0.00
0.00%
Total Non-Current Liabilities
17.62
5.98
11.64
194.65%
Current Liabilities
Trade Payables
2.57
0.06
2.51
4,183.33%
Other Current Liabilities
1.79
0.68
1.11
163.24%
Short Term Borrowings
3.05
0.00
3.05
0.00%
Short Term Provisions
2.74
0.05
2.69
5,380.00%
Total Current Liabilities
10.15
0.80
9.35
1,168.75%
Total Liabilities
12.91
47.07
-34.16
-72.57%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
27.76
0.15
27.61
18,406.67%
Less: Accumulated Depreciation
22.49
0.14
22.35
15,964.29%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
5.27
0.01
5.26
52,600.00%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.01
6.72
-6.71
-99.85%
Long Term Loans & Advances
1.29
38.80
-37.51
-96.68%
Other Non Current Assets
0.00
0.00
0.00
0.00%
Total Non-Current Assets
6.57
45.53
-38.96
-85.57%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
4.13
0.15
3.98
2,653.33%
Sundry Debtors
1.41
0.85
0.56
65.88%
Cash and Bank
0.04
0.21
-0.17
-80.95%
Other Current Assets
0.74
0.00
0.74
0.00%
Short Term Loans and Advances
0.02
0.33
-0.31
-93.94%
Total Current Assets
6.34
1.54
4.80
311.69%
Net Current Assets (Including Current Investments)
-3.81
0.74
-4.55
-614.86%
Total Current Assets Excluding Current Investments
6.34
1.54
4.80
311.69%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
12.91
47.07
-34.16
-72.57%
Contingent Liabilities
1.33
0.00
1.33
0.00%
Total Debt
21.58
5.71
15.87
277.93%
Book Value per share (adjusted)
-14.98
1.58
-16.56
-1,048.10%
Annual - Borrowings
Borrowings 21.58 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 0.28% vs 0.56% in Mar 2024
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 5.27 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -8.98% vs -10.51% in Mar 2024
Annual - Investments
Investments 0.01 Cr
in Mar 2025Figures in Cr
No Investments in the last few periods;
Annual - Current Assets
Current Assets 6.34 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 3.26% vs 24.80% in Mar 2024






